Dr. Hirushi Weerasinghe, MD

Dr. Weerasinghe practices at Emory Saint Joseph's Hospital in Atlanta, Georgia, part of Emory University.

Dr. Weerasinghe's NPI, 1396151080, was assigned on July 2, 2014. Dr. Weerasinghe holds Georgia license 85118.

Dr. Weerasinghe's primary practice is Emory Saint Joseph's Hospital, at 5665 Peachtree Dunwoody Road, Atlanta, GA 30342 in Fulton County. The practice phone is (678) 843-7001.

Dr. Weerasinghe's primary practice is Emory Saint Joseph's Hospital in Atlanta, Georgia, part of Emory University. Dr. Weerasinghe is also affiliated with Emory University Hospital Midtown. The medical group on file is Emory Clinic. Dmand AI also links Dr. Weerasinghe to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weerasinghe practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Weerasinghe's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Weerasinghe's licenses on file in 2 states: Georgia and New York.

CMS data shows 759 Medicare services from Dr. Weerasinghe across 5 procedure codes in 2024, for 330 Medicare patients. Medicare paid $64,304 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 330 Medicare patients who saw Dr. Weerasinghe in 2024. The largest group is 85 and over, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Weerasinghe's median patient age at 78, with 55% women.

In 2024, Dr. Weerasinghe wrote 394 Medicare Part D claims for 146 patients. 78% of them were for generic drugs. CMS names the drug for 186 of them, across 8 drugs with 11 or more claims each, at $44,429 in total drug cost. In 2023, CMS named 71 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Weerasinghe for performance year 2024, reported through an alternative payment model (APM). Dr. Weerasinghe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 23 general payments to Dr. Weerasinghe from 5 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $287.